Johannes Grillari
Department of Biotechnology
University of Natural Resources
Austria
Biography
Johannes Grillari’s research focus is on improving our understanding of the molecular and physiological changes that occur during cellular aging and their impact on aging of organisms. In addition, he is interested in engineering of mammalian cells to improved model systems and cell factories.Johannes Grillari has graduated in Biotechnology at the University of Natural Resources and Life Sciences Vienna (BOKU) in Austria, where he also accomplished his PhD in the field of cell aging in 1999. Since then he has founded and is leading the Aging and Immortalization Research group at the Department of Biotechnology at BOKU. He has worked as visiting scientist in the lab of Angus Lamond in Dundee, Scotland, for half a year in the field of RNA biology. In 2010 he was appointed Associate Professor, in 2011 he co-founded Evercyte, a company generating and providing immortalized cells for biopharmaceutical research and development. He has published more than 51 peer reviewed papers, holds 6 patents and has been invited speaker to more than 30 international conferences. Johannes Grillari’s research focus is on improving our understanding of the molecular and physiological changes that occur during cellular aging and their impact on aging of organisms. In addition, he is interested in engineering of mammalian cells to improved model systems and cell factories.Johannes Grillari has graduated in Biotechnology at the University of Natural Resources and Life Sciences Vienna (BOKU) in Austria, where he also accomplished his PhD in the field of cell aging in 1999. Since then he has founded and is leading the Aging and Immortalization Research group at the Department of Biotechnology at BOKU. He has worked as visiting scientist in the lab of Angus Lamond in Dundee, Scotland, for half a year in the field of RNA biology. In 2010 he was appointed Associate Professor, in 2011 he co-founded Evercyte, a company generating and providing immortalized cells for biopharmaceutical research and development. He has published more than 51 peer reviewed papers, holds 6 patents and has been invited speaker to more than 30 international conferences.
Research Interest
Cellular aging Replicative senescence RNA biology pre-mRNA splicing non-coding RNA miRNA Vesicle secretion DNA damage and repair Ubiquitin-proteasome system Biotechnology Recombinant protein production Chinese hamster ovary cells (CHO)
